| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tetralogy of Fallot | 13 | 2023 | 161 | 3.110 |
Why?
|
| Cardiac Surgical Procedures | 22 | 2023 | 1099 | 2.780 |
Why?
|
| Ventricular Outflow Obstruction | 8 | 2016 | 85 | 1.940 |
Why?
|
| Heart Defects, Congenital | 25 | 2024 | 1803 | 1.940 |
Why?
|
| Medical Errors | 4 | 2017 | 155 | 1.490 |
Why?
|
| Heart Ventricles | 11 | 2023 | 763 | 1.290 |
Why?
|
| Heart Valve Prosthesis Implantation | 9 | 2020 | 429 | 1.240 |
Why?
|
| Pulmonary Valve Insufficiency | 10 | 2023 | 39 | 1.160 |
Why?
|
| Pulmonary Artery | 5 | 2017 | 439 | 1.100 |
Why?
|
| Pulmonary Valve | 6 | 2020 | 94 | 1.060 |
Why?
|
| Aortic Valve | 4 | 2015 | 437 | 1.060 |
Why?
|
| Reoperation | 14 | 2021 | 819 | 0.960 |
Why?
|
| Pulmonary Valve Stenosis | 4 | 2020 | 40 | 0.900 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2016 | 140 | 0.890 |
Why?
|
| Heart-Assist Devices | 6 | 2024 | 1026 | 0.880 |
Why?
|
| Ventricular Function | 3 | 2015 | 92 | 0.850 |
Why?
|
| Heart Valve Diseases | 3 | 2016 | 166 | 0.820 |
Why?
|
| Heart Transplantation | 10 | 2024 | 854 | 0.800 |
Why?
|
| Hypoplastic Left Heart Syndrome | 7 | 2018 | 252 | 0.790 |
Why?
|
| Norwood Procedures | 4 | 2017 | 100 | 0.790 |
Why?
|
| Heart Failure | 8 | 2024 | 2131 | 0.780 |
Why?
|
| Vascular Surgical Procedures | 4 | 2021 | 568 | 0.780 |
Why?
|
| Fontan Procedure | 7 | 2022 | 182 | 0.780 |
Why?
|
| Cardiac Valve Annuloplasty | 2 | 2020 | 9 | 0.770 |
Why?
|
| Blalock-Taussig Procedure | 3 | 2017 | 50 | 0.740 |
Why?
|
| Risk Assessment | 13 | 2019 | 3336 | 0.730 |
Why?
|
| Treatment Outcome | 33 | 2024 | 12169 | 0.700 |
Why?
|
| Echocardiography | 8 | 2019 | 1049 | 0.660 |
Why?
|
| Postoperative Complications | 10 | 2021 | 3020 | 0.660 |
Why?
|
| Pilots | 1 | 2017 | 2 | 0.590 |
Why?
|
| Man-Machine Systems | 1 | 2017 | 7 | 0.590 |
Why?
|
| Aircraft | 1 | 2017 | 19 | 0.580 |
Why?
|
| Infant | 26 | 2024 | 12376 | 0.580 |
Why?
|
| Organ Sparing Treatments | 1 | 2017 | 34 | 0.580 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2019 | 360 | 0.570 |
Why?
|
| Surgical Flaps | 2 | 2017 | 206 | 0.570 |
Why?
|
| Attitude to Computers | 1 | 2017 | 49 | 0.570 |
Why?
|
| Infant, Newborn | 21 | 2019 | 8114 | 0.560 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 2 | 2021 | 28 | 0.540 |
Why?
|
| Follow-Up Studies | 16 | 2024 | 5056 | 0.530 |
Why?
|
| Humans | 75 | 2024 | 123259 | 0.510 |
Why?
|
| Survival Analysis | 10 | 2019 | 1473 | 0.450 |
Why?
|
| Health Status | 3 | 2019 | 375 | 0.450 |
Why?
|
| Abnormalities, Multiple | 3 | 2016 | 962 | 0.450 |
Why?
|
| Catheterization | 3 | 2012 | 237 | 0.440 |
Why?
|
| Retrospective Studies | 26 | 2024 | 16068 | 0.440 |
Why?
|
| Pulmonary Circulation | 2 | 2015 | 121 | 0.440 |
Why?
|
| Health Personnel | 1 | 2017 | 492 | 0.410 |
Why?
|
| Tricuspid Valve Insufficiency | 4 | 2020 | 63 | 0.410 |
Why?
|
| Male | 41 | 2024 | 60333 | 0.400 |
Why?
|
| Survivors | 2 | 2012 | 344 | 0.390 |
Why?
|
| Time Factors | 15 | 2024 | 6223 | 0.380 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 827 | 0.370 |
Why?
|
| Child | 20 | 2024 | 24256 | 0.370 |
Why?
|
| Age Factors | 7 | 2019 | 2811 | 0.370 |
Why?
|
| Graft Survival | 2 | 2024 | 530 | 0.360 |
Why?
|
| Female | 42 | 2024 | 65615 | 0.360 |
Why?
|
| Infant, Premature | 2 | 2017 | 807 | 0.360 |
Why?
|
| Bioprosthesis | 2 | 2010 | 111 | 0.350 |
Why?
|
| Risk Factors | 15 | 2019 | 10035 | 0.350 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 152 | 0.350 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2011 | 169 | 0.340 |
Why?
|
| Cyanosis | 1 | 2010 | 41 | 0.330 |
Why?
|
| Child, Preschool | 13 | 2024 | 13918 | 0.330 |
Why?
|
| Palliative Care | 7 | 2017 | 428 | 0.330 |
Why?
|
| Adult | 25 | 2024 | 29098 | 0.330 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2023 | 78 | 0.330 |
Why?
|
| Adolescent | 19 | 2024 | 19127 | 0.330 |
Why?
|
| Aorta | 2 | 2015 | 542 | 0.320 |
Why?
|
| Databases, Factual | 2 | 2017 | 1171 | 0.320 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2008 | 19 | 0.310 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2010 | 96 | 0.310 |
Why?
|
| Aortic Valve Stenosis | 2 | 2012 | 332 | 0.310 |
Why?
|
| Saphenous Vein | 1 | 2008 | 54 | 0.310 |
Why?
|
| Vascular Fistula | 1 | 2008 | 30 | 0.310 |
Why?
|
| Truncus Arteriosus | 1 | 2008 | 13 | 0.300 |
Why?
|
| Aneurysm | 1 | 2008 | 88 | 0.300 |
Why?
|
| Jugular Veins | 1 | 2008 | 75 | 0.290 |
Why?
|
| Prognosis | 9 | 2019 | 4511 | 0.290 |
Why?
|
| Cardiac Catheterization | 6 | 2019 | 630 | 0.290 |
Why?
|
| Brain Injuries | 2 | 2019 | 762 | 0.290 |
Why?
|
| Endocarditis, Bacterial | 1 | 2008 | 129 | 0.280 |
Why?
|
| Tracheal Stenosis | 1 | 2007 | 31 | 0.280 |
Why?
|
| Ischemic Preconditioning | 1 | 2007 | 18 | 0.280 |
Why?
|
| Diverticulum | 1 | 2007 | 28 | 0.280 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2007 | 41 | 0.280 |
Why?
|
| Subclavian Artery | 1 | 2007 | 71 | 0.280 |
Why?
|
| Prosthesis Implantation | 1 | 2008 | 143 | 0.270 |
Why?
|
| Oxygen Consumption | 3 | 2019 | 307 | 0.270 |
Why?
|
| Ontario | 3 | 2017 | 64 | 0.260 |
Why?
|
| United States National Aeronautics and Space Administration | 2 | 2016 | 19 | 0.260 |
Why?
|
| Quality of Life | 4 | 2023 | 1933 | 0.250 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 293 | 0.250 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2022 | 274 | 0.250 |
Why?
|
| Pediatrics | 1 | 2014 | 1141 | 0.240 |
Why?
|
| Coronary Artery Bypass | 1 | 2008 | 490 | 0.240 |
Why?
|
| Pulmonary Veins | 2 | 2021 | 161 | 0.240 |
Why?
|
| Aortic Diseases | 1 | 2007 | 198 | 0.240 |
Why?
|
| Societies, Medical | 1 | 2008 | 677 | 0.240 |
Why?
|
| Epidemiologic Methods | 3 | 2009 | 110 | 0.230 |
Why?
|
| Cohort Studies | 7 | 2020 | 4701 | 0.230 |
Why?
|
| Survival Rate | 5 | 2017 | 2002 | 0.230 |
Why?
|
| Heart Diseases | 1 | 2008 | 481 | 0.220 |
Why?
|
| Tricuspid Valve | 2 | 2015 | 59 | 0.210 |
Why?
|
| Allografts | 1 | 2024 | 192 | 0.210 |
Why?
|
| Biomedical Research | 1 | 2008 | 517 | 0.210 |
Why?
|
| Aorta, Thoracic | 1 | 2007 | 519 | 0.200 |
Why?
|
| Embolism, Air | 1 | 2022 | 25 | 0.200 |
Why?
|
| Young Adult | 9 | 2024 | 8867 | 0.200 |
Why?
|
| Double Outlet Right Ventricle | 2 | 2020 | 21 | 0.200 |
Why?
|
| Fetus | 2 | 2016 | 575 | 0.190 |
Why?
|
| Models, Statistical | 2 | 2016 | 471 | 0.190 |
Why?
|
| Severity of Illness Index | 6 | 2014 | 2854 | 0.190 |
Why?
|
| Tachycardia, Supraventricular | 2 | 2019 | 108 | 0.180 |
Why?
|
| Heterotaxy Syndrome | 1 | 2021 | 61 | 0.180 |
Why?
|
| Myocardium | 3 | 2024 | 986 | 0.180 |
Why?
|
| Middle Aged | 14 | 2024 | 26087 | 0.170 |
Why?
|
| Long Term Adverse Effects | 1 | 2020 | 12 | 0.170 |
Why?
|
| Graft Rejection | 1 | 2024 | 587 | 0.170 |
Why?
|
| Scimitar Syndrome | 1 | 2021 | 51 | 0.170 |
Why?
|
| Dextrocardia | 1 | 2020 | 9 | 0.170 |
Why?
|
| Heart Valve Prosthesis | 2 | 2016 | 293 | 0.170 |
Why?
|
| Situs Inversus | 1 | 2020 | 25 | 0.170 |
Why?
|
| Macrophages | 1 | 2024 | 604 | 0.170 |
Why?
|
| Canada | 5 | 2020 | 293 | 0.170 |
Why?
|
| Critical Care | 2 | 2019 | 648 | 0.170 |
Why?
|
| Prospective Studies | 8 | 2019 | 6030 | 0.160 |
Why?
|
| Terminal Care | 1 | 2019 | 112 | 0.150 |
Why?
|
| Transplantation, Homologous | 2 | 2011 | 659 | 0.150 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 174 | 0.150 |
Why?
|
| Patient Care Team | 2 | 2022 | 546 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2021 | 365 | 0.140 |
Why?
|
| Automation | 1 | 2017 | 59 | 0.140 |
Why?
|
| Disease Management | 2 | 2019 | 515 | 0.140 |
Why?
|
| Cardiology | 1 | 2022 | 474 | 0.140 |
Why?
|
| Length of Stay | 3 | 2020 | 1290 | 0.140 |
Why?
|
| Coronary Vessels | 2 | 2015 | 527 | 0.140 |
Why?
|
| Ventricular Dysfunction | 1 | 2017 | 24 | 0.140 |
Why?
|
| Operative Time | 1 | 2017 | 161 | 0.140 |
Why?
|
| Simulation Training | 1 | 2019 | 139 | 0.140 |
Why?
|
| Catheter Ablation | 1 | 2019 | 235 | 0.140 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 458 | 0.130 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 496 | 0.130 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2017 | 121 | 0.130 |
Why?
|
| Brain | 3 | 2019 | 2966 | 0.130 |
Why?
|
| Ventricular Function, Right | 3 | 2023 | 112 | 0.130 |
Why?
|
| Stroke | 1 | 2023 | 958 | 0.130 |
Why?
|
| Equipment Design | 1 | 2017 | 604 | 0.120 |
Why?
|
| Tricuspid Atresia | 1 | 2015 | 14 | 0.120 |
Why?
|
| Patient Selection | 2 | 2009 | 683 | 0.120 |
Why?
|
| Propensity Score | 1 | 2016 | 212 | 0.120 |
Why?
|
| Surgeons | 1 | 2019 | 249 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 503 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 434 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2019 | 580 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 478 | 0.110 |
Why?
|
| Stents | 3 | 2016 | 876 | 0.110 |
Why?
|
| United States | 4 | 2016 | 10652 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2019 | 624 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2015 | 1012 | 0.110 |
Why?
|
| Heart Aneurysm | 1 | 2013 | 38 | 0.100 |
Why?
|
| Birth Weight | 2 | 2016 | 339 | 0.100 |
Why?
|
| Renal Dialysis | 1 | 2019 | 844 | 0.100 |
Why?
|
| Heart Septal Defects | 2 | 2012 | 40 | 0.100 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2013 | 37 | 0.100 |
Why?
|
| Heart Atria | 2 | 2019 | 313 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1253 | 0.100 |
Why?
|
| Ductus Arteriosus | 1 | 2013 | 63 | 0.100 |
Why?
|
| Thrombosis | 1 | 2017 | 518 | 0.100 |
Why?
|
| Aortic Coarctation | 1 | 2012 | 105 | 0.090 |
Why?
|
| Aged | 3 | 2021 | 19195 | 0.090 |
Why?
|
| Terminology as Topic | 1 | 2012 | 228 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 2058 | 0.080 |
Why?
|
| Vena Cava, Superior | 1 | 2010 | 55 | 0.080 |
Why?
|
| Arteriovenous Malformations | 1 | 2010 | 46 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2011 | 197 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2019 | 1160 | 0.080 |
Why?
|
| Viridans Streptococci | 1 | 2008 | 8 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 3383 | 0.080 |
Why?
|
| Coronary Circulation | 2 | 2009 | 209 | 0.080 |
Why?
|
| Williams Syndrome | 1 | 2008 | 39 | 0.080 |
Why?
|
| Pulmonary Atresia | 1 | 2008 | 48 | 0.080 |
Why?
|
| Heat-Shock Proteins | 2 | 1999 | 194 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 1999 | 206 | 0.070 |
Why?
|
| Angiography | 1 | 2008 | 215 | 0.070 |
Why?
|
| Echocardiography, Doppler | 1 | 2008 | 170 | 0.070 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 71 | 0.070 |
Why?
|
| Time | 1 | 2008 | 94 | 0.070 |
Why?
|
| Phenotype | 1 | 2017 | 4228 | 0.070 |
Why?
|
| Registries | 1 | 2014 | 1398 | 0.070 |
Why?
|
| Mitral Valve | 1 | 2009 | 245 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 138 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 254 | 0.070 |
Why?
|
| Prosthesis Failure | 1 | 2008 | 159 | 0.070 |
Why?
|
| Respiratory Sounds | 1 | 2007 | 69 | 0.070 |
Why?
|
| Cattle | 1 | 2008 | 562 | 0.070 |
Why?
|
| Hospital Mortality | 3 | 2019 | 1013 | 0.070 |
Why?
|
| Swine | 2 | 2007 | 1167 | 0.070 |
Why?
|
| Bronchoscopy | 1 | 2007 | 153 | 0.070 |
Why?
|
| Dyspnea | 1 | 2007 | 147 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 2 | 2022 | 430 | 0.060 |
Why?
|
| Streptococcal Infections | 1 | 2008 | 244 | 0.060 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2018 | 149 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 330 | 0.060 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2005 | 52 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2008 | 675 | 0.060 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2017 | 114 | 0.060 |
Why?
|
| Comorbidity | 2 | 2019 | 1497 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2005 | 166 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 220 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3549 | 0.060 |
Why?
|
| Decision Making | 1 | 2008 | 652 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 553 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2007 | 1002 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 2114 | 0.050 |
Why?
|
| Animals | 6 | 2019 | 33857 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1450 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 89 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 118 | 0.050 |
Why?
|
| Organizational Culture | 1 | 2022 | 94 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 263 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2844 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 3676 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 319 | 0.050 |
Why?
|
| Perfusion | 1 | 2022 | 200 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2023 | 446 | 0.050 |
Why?
|
| Shock, Cardiogenic | 1 | 2022 | 190 | 0.050 |
Why?
|
| Machine Learning | 1 | 2023 | 220 | 0.040 |
Why?
|
| Algorithms | 1 | 2007 | 1598 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2021 | 335 | 0.040 |
Why?
|
| Leadership | 1 | 2022 | 226 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2020 | 73 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 240 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2022 | 421 | 0.040 |
Why?
|
| Tachycardia | 1 | 2019 | 68 | 0.040 |
Why?
|
| Models, Anatomic | 1 | 2020 | 98 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 136 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 288 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2020 | 238 | 0.040 |
Why?
|
| Printing, Three-Dimensional | 1 | 2019 | 68 | 0.040 |
Why?
|
| Incidence | 2 | 2017 | 3053 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2019 | 180 | 0.040 |
Why?
|
| Transposition of Great Vessels | 1 | 2019 | 131 | 0.040 |
Why?
|
| Heart | 1 | 2022 | 723 | 0.040 |
Why?
|
| Pregnancy | 3 | 2016 | 7129 | 0.040 |
Why?
|
| Models, Animal | 1 | 2019 | 466 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 1418 | 0.030 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2019 | 274 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 257 | 0.030 |
Why?
|
| Fibrosis | 1 | 2018 | 429 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2019 | 344 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 632 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2014 | 1389 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2019 | 332 | 0.030 |
Why?
|
| Cell Movement | 1 | 1999 | 831 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1239 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 1999 | 332 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 858 | 0.030 |
Why?
|
| Biopsy | 1 | 2018 | 1236 | 0.030 |
Why?
|
| Replantation | 1 | 2015 | 54 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2015 | 107 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2015 | 204 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2015 | 213 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2016 | 437 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 463 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 419 | 0.030 |
Why?
|
| Curriculum | 1 | 2019 | 714 | 0.030 |
Why?
|
| Oximetry | 1 | 2015 | 160 | 0.030 |
Why?
|
| Oxygen | 1 | 2017 | 550 | 0.030 |
Why?
|
| Gestational Age | 1 | 2017 | 1137 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 2030 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 2013 | 47 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 2409 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1006 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2019 | 972 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2017 | 958 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2013 | 125 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 772 | 0.020 |
Why?
|
| Siblings | 1 | 2012 | 196 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2015 | 843 | 0.020 |
Why?
|
| Cineangiography | 1 | 2009 | 15 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 625 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2009 | 43 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2009 | 167 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 1999 | 131 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1414 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3239 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2009 | 161 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1801 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2009 | 294 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 904 | 0.020 |
Why?
|
| Exercise | 1 | 2012 | 814 | 0.020 |
Why?
|
| Computer Systems | 1 | 2005 | 38 | 0.020 |
Why?
|
| Phosphorylation | 2 | 1999 | 1613 | 0.020 |
Why?
|
| Fluorocarbons | 1 | 2005 | 56 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 449 | 0.010 |
Why?
|
| Contrast Media | 1 | 2005 | 471 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1999 | 42 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1999 | 143 | 0.010 |
Why?
|
| Dogs | 1 | 1999 | 764 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1999 | 456 | 0.010 |
Why?
|
| Adenoviridae | 1 | 1999 | 604 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 1218 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1999 | 3046 | 0.010 |
Why?
|
| Rats | 1 | 1999 | 3666 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1999 | 4501 | 0.000 |
Why?
|